Study finds cycling JAK inhibitors to be an effective option for patients with difficult-to-treat rheumatoid arthritis
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with difficult-to-treat rheumatoid arthritis who do not have success with one Janus kinase inhibitor ...
Nov 2, 2021
0
1